Stock listing
Volitionrx Limited
Selected listing: VNRX · AMEX · USD · US
Volitionrx Limited (NYSE American: VNRX), Health Technology. Latest release Sep 14, 2026: VolitionRx Limited Announces Pre-Payment in Full of $7.5 million…
- Ticker
- NYSE American: VNRX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NYSE American
- Currency
- USD
About Volitionrx Limited
The company focuses on developing innovative diagnostic tests for various diseases, leveraging its proprietary technology. VolitionRx aims to improve healthcare outcomes through early detection and diagnosis.
Latest news from Volitionrx Limited
VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027
September 14, 2026
Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis
August 26, 2026
VolitionRx : Announces Second Quarter 2026 Financial Results and Business Update
August 13, 2026
Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients
August 12, 2026
VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update
August 12, 2026